Port site infiltration of local anesthetic after laparoendoscopic single site surgery for benign adnexal disease.

OBJECTIVE

To determine whether local bupivacaine injection into the incision site after gynecologic laparoendoscopic single site surgery (LESS) improves postoperative pain.

METHODS

This prospective cohort study included consecutive 158 patients who had LESS for benign adnexal disease from March 2013 to December 2015. Chronologically, 82 patients (March 2013 to August 2014) received no bupivacaine (group 1) and 76 (August 2014 to December 2015) received a bupivacaine block (group 2). For group 2, 10 mL 0.25% bupivacaine was injected into the 20 mm-incision site through all preperitoneal layers after LESS completion. Primary outcome is postoperative pain score using the visual analog scale (VAS).

RESULTS

There was no difference in clinicopathological characteristics between the groups. Operating time (expressed as median [range], 92 [55-222] vs. 100 [50-185] minutes, =0.137) and estimated blood loss (50 [30-1,500] vs. 125 [30-1,000] mL, =0.482) were similar between the groups. Post-surgical VAS pain scores after 3 hours (3.5 [2-6] vs. 3.5 [2-5], =0.478), 6 to 8 hours (3.5 [2-6] vs. 3 [1-8], =0.478), and 16 to 24 hours (3 [2-4] vs. 3 [1-7], =0.664) did not differ between groups.

CONCLUSION

Bupivacaine injection into the trocar site did not improve postoperative pain after LESS. Randomized trials are needed to evaluate the benefits of local bupivacaine anesthetic for postoperative pain reduction.